<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: <z:mp ids='MP_0000248'>Macrocytosis</z:mp> is a relatively common finding in adult patients undergoing blood cell counting </plain></SENT>
<SENT sid="1" pm="."><plain>Approximately 10% of patients will have unexplained <z:mp ids='MP_0000248'>macrocytosis</z:mp> after laboratory evaluation </plain></SENT>
<SENT sid="2" pm="."><plain>Data on the approach to patients with unexplained <z:mp ids='MP_0000248'>macrocytosis</z:mp> are limited </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: To investigate this topic and help delineate an approach to this condition, the records of 9779 patients diagnosed in our institution between 1995 and 2005 as having <z:mp ids='MP_0000248'>macrocytosis</z:mp> were reviewed </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with evidence of <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e>, <z:e sem="disease" ids="C0085762" disease_type="Mental or Behavioral Dysfunction" abbrv="aca">alcohol abuse</z:e>, <z:hpo ids='HP_0000821'>hypothyroidism</z:hpo>, <z:chebi fb="3" ids="37445">folate</z:chebi> or <z:hpo ids='HP_0100502'>vitamin B12 deficiency</z:hpo>, <z:mp ids='MP_0010163'>hemolysis</z:mp>, or use of any drugs known to cause <z:mp ids='MP_0000248'>macrocytosis</z:mp> were excluded </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Forty-three patients were found to have unexplained <z:mp ids='MP_0000248'>macrocytosis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The median follow-up was 4 years </plain></SENT>
<SENT sid="7" pm="."><plain>A total of 11.6% patients developed a primary <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorder</z:e> (two B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, two with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, one <z:e sem="disease" ids="C1136084" disease_type="Neoplastic Process" abbrv="">plasma cell disorder</z:e>), 16.3% developed worsening cytopenias, 69.7% had stable disease, and 2.3% resolved </plain></SENT>
<SENT sid="8" pm="."><plain>The median time to first cytopenia was 18 months, and the mean time to diagnosis of <z:e sem="disease" ids="C0005956" disease_type="Disease or Syndrome" abbrv="">bone marrow disorder</z:e> was 31.6 months </plain></SENT>
<SENT sid="9" pm="."><plain>The outcomes were not significantly different when comparing patients with or without <z:hpo ids='HP_0001903'>anemia</z:hpo> upon diagnosis </plain></SENT>
<SENT sid="10" pm="."><plain>The probability of a bone marrow biopsy to establish a diagnosis of a primary disorder was 33.3% in patients with <z:mp ids='MP_0000248'>macrocytosis</z:mp> without <z:hpo ids='HP_0001903'>anemia</z:hpo> compared with 75% in patients with <z:mp ids='MP_0000248'>macrocytosis</z:mp> with <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Patients with unexplained <z:mp ids='MP_0000248'>macrocytosis</z:mp> still require close follow-up </plain></SENT>
<SENT sid="12" pm="."><plain>We suggest a strategy of follow-up with blood cell counting every 6 months </plain></SENT>
<SENT sid="13" pm="."><plain>Bone marrow biopsy should be performed when cytopenias are present because this approach may provide a higher yield of diagnosis and aid with therapeutic decisions </plain></SENT>
</text></document>